The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Clinical Trials Imaging-Global Market Insights and Sales Trends 2024
Synopsis
Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
The global Clinical Trials Imaging market size is expected to reach US$ 2281.9 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029. The market is mainly driven by the significant applications of Clinical Trials Imaging in various end use industries. The expanding demands from the Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Medical Device Manufacturers, are propelling Clinical Trials Imaging market. Computed Tomography, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ultrasound segment is estimated at % CAGR for the next seven-year period.
Global core clinical trial imaging manufacturers include ICON, ERT, McLaren etc.The top 5 companies hold a share about 40%.North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific with the share about 27% and 27%.In terms of product, central imaging service is the largest segment, with a share about 70%. And in terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Clinical Trials Imaging, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Clinical Trials Imaging market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Clinical Trials Imaging market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Clinical Trials Imaging sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Clinical Trials Imaging covered in this report include Bioclinica, Parexel International, Radiant Sage, Biomedical Systems, Biotelemetry, Icon, IXICO, Cardiovascular Imaging Technologies and Intrinsic Imaging, etc.
The global Clinical Trials Imaging market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bioclinica
Parexel International
Radiant Sage
Biomedical Systems
Biotelemetry
Icon
IXICO
Cardiovascular Imaging Technologies
Intrinsic Imaging
Worldcare Clinical
Virtualscopics
Global Clinical Trials Imaging market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Clinical Trials Imaging market, Segment by Type:
Computed Tomography
Ultrasound
Echocardiography
Magnetic Resonance Imaging
Positron Emission Tomography
X-Ray
Other Modalities
Global Clinical Trials Imaging market, by Application
Biotechnology Companies
Pharmaceutical Companies
Contract Research Organizations
Medical Device Manufacturers
Academic and Government Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Clinical Trials Imaging companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
The global Clinical Trials Imaging market size is expected to reach US$ 2281.9 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029. The market is mainly driven by the significant applications of Clinical Trials Imaging in various end use industries. The expanding demands from the Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Medical Device Manufacturers, are propelling Clinical Trials Imaging market. Computed Tomography, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ultrasound segment is estimated at % CAGR for the next seven-year period.
Global core clinical trial imaging manufacturers include ICON, ERT, McLaren etc.The top 5 companies hold a share about 40%.North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific with the share about 27% and 27%.In terms of product, central imaging service is the largest segment, with a share about 70%. And in terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Clinical Trials Imaging, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Clinical Trials Imaging market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Clinical Trials Imaging market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Clinical Trials Imaging sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Clinical Trials Imaging covered in this report include Bioclinica, Parexel International, Radiant Sage, Biomedical Systems, Biotelemetry, Icon, IXICO, Cardiovascular Imaging Technologies and Intrinsic Imaging, etc.
The global Clinical Trials Imaging market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bioclinica
Parexel International
Radiant Sage
Biomedical Systems
Biotelemetry
Icon
IXICO
Cardiovascular Imaging Technologies
Intrinsic Imaging
Worldcare Clinical
Virtualscopics
Global Clinical Trials Imaging market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Clinical Trials Imaging market, Segment by Type:
Computed Tomography
Ultrasound
Echocardiography
Magnetic Resonance Imaging
Positron Emission Tomography
X-Ray
Other Modalities
Global Clinical Trials Imaging market, by Application
Biotechnology Companies
Pharmaceutical Companies
Contract Research Organizations
Medical Device Manufacturers
Academic and Government Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Clinical Trials Imaging companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Clinical Trials Imaging
1.1 Clinical Trials Imaging Market Overview
1.1.1 Clinical Trials Imaging Product Scope
1.1.2 Clinical Trials Imaging Market Status and Outlook
1.2 Global Clinical Trials Imaging Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Clinical Trials Imaging Market Size by Region (2018-2029)
1.4 Global Clinical Trials Imaging Historic Market Size by Region (2018-2023)
1.5 Global Clinical Trials Imaging Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Clinical Trials Imaging Market Size (2018-2029)
1.6.1 North America Clinical Trials Imaging Market Size (2018-2029)
1.6.2 Europe Clinical Trials Imaging Market Size (2018-2029)
1.6.3 Asia-Pacific Clinical Trials Imaging Market Size (2018-2029)
1.6.4 Latin America Clinical Trials Imaging Market Size (2018-2029)
1.6.5 Middle East & Africa Clinical Trials Imaging Market Size (2018-2029)
2 Clinical Trials Imaging Market by Type
2.1 Introduction
2.1.1 Computed Tomography
2.1.2 Ultrasound
2.1.3 Echocardiography
2.1.4 Magnetic Resonance Imaging
2.1.5 Positron Emission Tomography
2.1.6 X-Ray
2.1.7 Other Modalities
2.2 Global Clinical Trials Imaging Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Clinical Trials Imaging Historic Market Size by Type (2018-2023)
2.2.2 Global Clinical Trials Imaging Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Clinical Trials Imaging Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Clinical Trials Imaging Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Clinical Trials Imaging Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Clinical Trials Imaging Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Clinical Trials Imaging Revenue Breakdown by Type (2018-2029)
3 Clinical Trials Imaging Market Overview by Application
3.1 Introduction
3.1.1 Biotechnology Companies
3.1.2 Pharmaceutical Companies
3.1.3 Contract Research Organizations
3.1.4 Medical Device Manufacturers
3.1.5 Academic and Government Research Institutes
3.1.6 Others
3.2 Global Clinical Trials Imaging Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Clinical Trials Imaging Historic Market Size by Application (2018-2023)
3.2.2 Global Clinical Trials Imaging Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Clinical Trials Imaging Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Clinical Trials Imaging Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Clinical Trials Imaging Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Clinical Trials Imaging Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Clinical Trials Imaging Revenue Breakdown by Application (2018-2029)
4 Clinical Trials Imaging Competition Analysis by Players
4.1 Global Clinical Trials Imaging Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Clinical Trials Imaging as of 2022)
4.3 Date of Key Players Enter into Clinical Trials Imaging Market
4.4 Global Top Players Clinical Trials Imaging Headquarters and Area Served
4.5 Key Players Clinical Trials Imaging Product Solution and Service
4.6 Competitive Status
4.6.1 Clinical Trials Imaging Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bioclinica
5.1.1 Bioclinica Profile
5.1.2 Bioclinica Main Business
5.1.3 Bioclinica Clinical Trials Imaging Products, Services and Solutions
5.1.4 Bioclinica Clinical Trials Imaging Revenue (US$ Million) & (2018-2023)
5.1.5 Bioclinica Recent Developments
5.2 Parexel International
5.2.1 Parexel International Profile
5.2.2 Parexel International Main Business
5.2.3 Parexel International Clinical Trials Imaging Products, Services and Solutions
5.2.4 Parexel International Clinical Trials Imaging Revenue (US$ Million) & (2018-2023)
5.2.5 Parexel International Recent Developments
5.3 Radiant Sage
5.3.1 Radiant Sage Profile
5.3.2 Radiant Sage Main Business
5.3.3 Radiant Sage Clinical Trials Imaging Products, Services and Solutions
5.3.4 Radiant Sage Clinical Trials Imaging Revenue (US$ Million) & (2018-2023)
5.3.5 Biomedical Systems Recent Developments
5.4 Biomedical Systems
5.4.1 Biomedical Systems Profile
5.4.2 Biomedical Systems Main Business
5.4.3 Biomedical Systems Clinical Trials Imaging Products, Services and Solutions
5.4.4 Biomedical Systems Clinical Trials Imaging Revenue (US$ Million) & (2018-2023)
5.4.5 Biomedical Systems Recent Developments
5.5 Biotelemetry
5.5.1 Biotelemetry Profile
5.5.2 Biotelemetry Main Business
5.5.3 Biotelemetry Clinical Trials Imaging Products, Services and Solutions
5.5.4 Biotelemetry Clinical Trials Imaging Revenue (US$ Million) & (2018-2023)
5.5.5 Biotelemetry Recent Developments
5.6 Icon
5.6.1 Icon Profile
5.6.2 Icon Main Business
5.6.3 Icon Clinical Trials Imaging Products, Services and Solutions
5.6.4 Icon Clinical Trials Imaging Revenue (US$ Million) & (2018-2023)
5.6.5 Icon Recent Developments
5.7 IXICO
5.7.1 IXICO Profile
5.7.2 IXICO Main Business
5.7.3 IXICO Clinical Trials Imaging Products, Services and Solutions
5.7.4 IXICO Clinical Trials Imaging Revenue (US$ Million) & (2018-2023)
5.7.5 IXICO Recent Developments
5.8 Cardiovascular Imaging Technologies
5.8.1 Cardiovascular Imaging Technologies Profile
5.8.2 Cardiovascular Imaging Technologies Main Business
5.8.3 Cardiovascular Imaging Technologies Clinical Trials Imaging Products, Services and Solutions
5.8.4 Cardiovascular Imaging Technologies Clinical Trials Imaging Revenue (US$ Million) & (2018-2023)
5.8.5 Cardiovascular Imaging Technologies Recent Developments
5.9 Intrinsic Imaging
5.9.1 Intrinsic Imaging Profile
5.9.2 Intrinsic Imaging Main Business
5.9.3 Intrinsic Imaging Clinical Trials Imaging Products, Services and Solutions
5.9.4 Intrinsic Imaging Clinical Trials Imaging Revenue (US$ Million) & (2018-2023)
5.9.5 Intrinsic Imaging Recent Developments
5.10 Worldcare Clinical
5.10.1 Worldcare Clinical Profile
5.10.2 Worldcare Clinical Main Business
5.10.3 Worldcare Clinical Clinical Trials Imaging Products, Services and Solutions
5.10.4 Worldcare Clinical Clinical Trials Imaging Revenue (US$ Million) & (2018-2023)
5.10.5 Worldcare Clinical Recent Developments
5.11 Virtualscopics
5.11.1 Virtualscopics Profile
5.11.2 Virtualscopics Main Business
5.11.3 Virtualscopics Clinical Trials Imaging Products, Services and Solutions
5.11.4 Virtualscopics Clinical Trials Imaging Revenue (US$ Million) & (2018-2023)
5.11.5 Virtualscopics Recent Developments
6 North America
6.1 North America Clinical Trials Imaging Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Clinical Trials Imaging Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trials Imaging Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Clinical Trials Imaging Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trials Imaging Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Clinical Trials Imaging Market Dynamics
11.1 Clinical Trials Imaging Industry Trends
11.2 Clinical Trials Imaging Market Drivers
11.3 Clinical Trials Imaging Market Challenges
11.4 Clinical Trials Imaging Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
